This laboratory developes management and technical field skills, complying with the ISO/IEC 17025:2017 for calibration laboratory accreditation, received in 2022. Its result of calibrations are recognized worldwide.

The Laboratory has four scopes: pipette type A, weighing balance, Mass and temperature mapping.

This biobank focuses on:

The Animal Research Lab (ANL) is responsible for designing animal experiment models for various diseases and conducting in vivo experiments to investigate the efficacy of infectious disease vaccines and therapeutic candidates. ANL also conducts preclinical research on animal experiments to evaluate the practical use of the results obtained through basic and translational research at IPK. In particular, ANL establishes new drug candidate evaluation platforms and manages the welfare and housing of research animals.

The Animal Research Lab capabilities/assets includes:

The Medicinal Chemistry team focuses on the optimization of compounds which are identified as effective against target diseases through primary screening.

The areas of activity include:

Our objective is to create customized, cost-effective tool and instrument utilizing readily available technology to address scientific needs. Once you reach out to us, we will arrange a teleconference meeting to delve into the project. Subsequently, we will engage in an iterative interaction, progressing from the initial design concept to the actual creation of the tool or instrument. This comprehensive approach may span several months to ensure a successful and satisfying outcome

Our platform facilitates the exploration of protein-protein interactions (PPI) within living cells, utilizing a diverse range of high-throughput methods. We harness the power of the Bioluminescence Resonance Energy Transfer (BRET) technique for the precise quantification of proteins of interest, including, for example, pathogen/host protein pairs. What distinguishes our method is its capability to continuously monitor these interactions in real time within living cells for extended durations. This versatile approach supports a wide array of applications, including PPI validation, time-lapse PPI cell quantification, assessment of affinity in mutant PPI pairs, PPI competition studies, and screening for PPI modulators in drug discovery.

The production and research complex of Pasteur Institute of Iran was founded in 1988 on the Tehran Karaj Highway. It was established to meet the increasing population demand for products such as various solutions and vaccines and providing requirements for research like different laboratory animals

The Sequencing Platform is intended to strengthen research activities and public health response related to genomic sequencing within the institute and regional collaborators.

It has a crosscutting role that supports the research units and testing laboratories of IPC with various materials, including documents such as standard operating procedures (SOPs), and software to monitor the samples

This platform allows researchers to investigate complex pathogen–host interactions at single-cell level directly on site in a low/middle income country. The availability of this equipment and of patient cohorts in the same location allows us to advance our basic research on infectious diseases in Cambodia, which is of major importance.